Your browser doesn't support javascript.
loading
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk.
Corre, Jill; Montes, Lydia; Martin, Elodie; Perrot, Aurore; Caillot, Denis; Leleu, Xavier; Belhadj, Karim; Facon, Thierry; Hulin, Cyrille; Mohty, Mohamad; Fontan, Jean; Macro, Margaret; Brechignac, Sabine; Jaccard, Arnaud; Stoppa, Anne-Marie; Orsini-Piocelle, Frederique; Adiko, Didier; Voillat, Laurent; Keddar, Faiza; Barry, Marly; Demarquette, Helene; Certain, Marie-Noelle; Plantier, Isabelle; Roussel, Murielle; Hébraud, Benjamin; Filleron, Thomas; Attal, Michel; Avet-Loiseau, Hervé.
Afiliação
  • Corre J; Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, Toulouse. corre.jill@iuct-oncopole.fr.
  • Montes L; Hematology Department, University Hospital, Amiens.
  • Martin E; Biostatistics Department, Institut Claudius Regaud, IUCT-O, Toulouse.
  • Perrot A; Hematology Department, University Hospital, Nancy.
  • Caillot D; Hematology Department, University Hospital, Dijon.
  • Leleu X; Hematology Department, University Hospital, Poitiers.
  • Belhadj K; Hematology Department, University Hospital, Créteil.
  • Facon T; Hematology Department, University Hospital, Lille.
  • Hulin C; Hematology Department, University Hospital, Bordeaux.
  • Mohty M; Hematology Department, University Hospital, Paris.
  • Fontan J; Hematology Department, University Hospital, Besancon.
  • Macro M; Hematology Department, University Hospital, Caen.
  • Brechignac S; Hematology Department, University Hospital, Bobigny.
  • Jaccard A; Hematology Department, University Hospital, Limoges.
  • Stoppa AM; Hematology Department, Institut Paoli Calmettes, Marseille.
  • Orsini-Piocelle F; Hematology Department, Department Hospital, Annecy.
  • Adiko D; Hematology Department, Department Hospital, Libourne.
  • Voillat L; Hematology Department, Department Hospital, Chalon-sur-Saône.
  • Keddar F; Hematology Department, Department Hospital, Valenciennes.
  • Barry M; Hematology Department, Department Hospital, Boulogne-Sur-Mer.
  • Demarquette H; Hematology Department, Department Hospital, Dunkerque.
  • Certain MN; Hematology Department, Department Hospital, Mâcon.
  • Plantier I; Hematology Department, Department Hospital, Roubaix.
  • Roussel M; Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
  • Hébraud B; Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
  • Filleron T; Biostatistics Department, Institut Claudius Regaud, IUCT-O, Toulouse.
  • Attal M; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, Toulouse; Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
  • Avet-Loiseau H; Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche Médicale U1037, Toulouse.
Haematologica ; 105(9): e480-483, 2020 09 01.
Article em En | MEDLINE | ID: mdl-33054068

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article
...